Mandatory notification of trade

07. Apr 2025 | 1 min read

Moss, 7 April 2025

Gentian Diagnostics ASA ("Gentian") has today been notified that the following transaction has been completed by a close associate of a primary insider in Gentian:

Kjersti Grimsrud, a board member and primary insider in Gentian, has purchased 5,000 shares in Gentian at NOK 46.20 per share.

PCA notification pursuant to the EU Market Abuse Regulation Article 19 is attached.

This information is subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act, EU Market Abuse Regulation Article 19 and Euronext Oslo Rule Book II.

For further information, please contact:

Njaal Kind, Group CFO,
njaal.kind@gentian.no
 +47 91 90 65 25

You may also read


Jul 02, 2026 - Ole Sørlie

Gentian Diagnostics: Invitation to presentation of second quarter results

Gentian Diagnostics ASA will present its second quarter 2026 results on 9 July 2026 at 09.00 CEST. The..

Jun 24, 2026 - Ole Sørlie

ESSANGE REAGENTS AND GENTIAN DIAGNOSTICS ANNOUNCE COLLABORATION AGREEMENT

Amsterdam / Moss, 24 June 2026 ESSANGE REAGENTS AND GENTIAN DIAGNOSTICS ANNOUNCE COLLABORATION AGREEMENT..

May 29, 2026 - Ole Sørlie

Mandatory notification of trade

Moss, 29 May 2026 Gentian Diagnostics ASA ("Gentian") has today been notified that the following transaction..